Search

everythinglearnresearchcommunity

for

Search:↓

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Frontal fibrosing alopecia might be linked to autoimmune diseases.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Oral minipulse therapy effectively treated bullous lichen planus in a 35-year-old woman.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.